Results indicate that PRMT6 is upregulated in breast cancer, compared with normal tissues; higher levels of PRMT6 were correlated with poor overall survival in patients with breast cancer (Figure 1A,B), confirming that PRMT6 expression is associated with breast cancer development, as previously reported.[14]. This evidence concerns the gene PRMT6 and breast carcinoma.